Organisation paid for research Program year 2025 Source: CMS Open Payments

West Broadway Clinic PC

Neither a doctor nor a teaching hospital

Research payments

$740,123

185 payments

Through program year 2025, West Broadway Clinic PC is reported as receiving $740,123 in research payments, across 185 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $315,113 36
2024 Research $85,590 16
2023 Research $7,423 3
2022 Research $48,336 43
2021 Research $94,413 45
2020 Research $111,844 34
2019 Research $77,404 8

Breakdown

Who paid Research payments · program years 2019–2025
  1. AbbVie, Inc. $471,681 110 payments
  2. Kowa Research Institute, Inc. $187,304 36 payments
  3. Ionis Pharmaceuticals, Inc. $59,781 6 payments
  4. Esperion Therapeutics, Inc. $21,357 33 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $283,342 34 payments
  2. K-877-302 $126,606 22 payments
  3. K-877-302 $60,699 14 payments
  4. Is354cs9 $54,206 4 payments
  5. M16-100 $50,048 17 payments
  6. Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study $38,775 15 payments
  7. A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men $36,769 29 payments
  8. M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $26,014 5 payments
  9. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (Etc-1002) on the Occurrence of Major Cardiovascular Events in Patients With, Or at High Risk For, Cardiovascular Disease Who Are Statin Intolerant $21,357 33 payments
  10. A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism $13,370 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record